Research Directory

The patent battle over CRISPR rages on

Read more

Working with patients to accelerate drug development

Read more

The future of RNAi in the age of gene editing

Read more

European biotechs post modest Q2 gains

Read more

The risks of therapeutic genome editing

Read more

European biotech searches for growth capital

Read more

Janssen Oncology: When the data show durable response

Read more

Real-world evidence - the new healthcare currency

Read more

Case study - the merits of adaptive trial design

Read more

The next step for EU health technology assessment

Read more